ARQTArcutis Biotherapeutics, Inc.

$25.16

Who owns ARQT

263 institutions reported holding ARQT for 2026Q1, together 102% of the company, fewer than the 277 a quarter earlier.

263

Institutions reporting a position · as of 2026Q1 · down from 277 the quarter before

Shares held by institutions
131.8M

Shares held by institutions · 102% of the company · long US equity positions only, as reported on Form 13F

Reported value
$3.10B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
37%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
25
New positions
32
Positions exited
51
Added to
100
Reduced
80
Top 10 holdersof the company
56%
Institutional ownership by quarter, 2020Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q1263131.8M$3.10B
2025Q4277128.7M$3.73B
2025Q3236125.6M$2.37B
2025Q2225126.7M$1.78B
2025Q1239125.7M$1.97B
2024Q4205128.8M$1.79B
2024Q3184128.1M$1.19B
2024Q2184125.9M$1.17B
2024Q1167125.0M$1.24B
2023Q4133101.3M$327M
2023Q313367.2M$357M
2023Q213571.8M$684M
2023Q114171.5M$787M
2022Q414166.1M$980M
2022Q313859.4M$1.13B
2022Q211449.1M$1.05B
Largest reported holders, 2026Q1
HolderShares% of companyValue
SUVRETTA CAPITAL MANAGEMENT, LLC12.3M9.5%$290M
Frazier Life Sciences Management, L.P.9.9M7.6%$233M
BlackRock Inc.9.2M7.1%$217M
Rubric Capital Management LP8.3M6.4%$195M
VANGUARD GROUP INC7.8M6.0%$183M
STATE STREET CORP6.3M4.9%$148M
Polar Capital Holdings Plc5.7M4.4%$134M
JENNISON ASSOCIATES LLC5.0M3.9%$117M
GILDER GAGNON HOWE & CO LLC4.3M3.3%$101M
MORGAN STANLEY4.2M3.3%$99M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…